AUROBINDO PHARMA LTD.

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
10-Nov-21 KR Choksey Aurobindo reported Revenue de-growth of 8.4% YoY (+4.2% QoQ) to I.. ACCUMULATE 677 756 11.67
13-Aug-21 Isec Significant revenue miss due to US, ARVs… Buy 770 865 12.34
12-Nov-20 Isec In line numbers with better gross margins… Buy 850 1025 20.6
27-Sep-20 Motilal Oswal Development of complex pipeline on track Buy 772 1030 33.4
13-Aug-20 Isec In line numbers; US steady despite injectables drop Buy 896 1100 22.8


Analyst Calls / Meets


Management Interviews

No Management Interviews.

Investor Presentations


Annual Reports
Source: Reportjunction.com

2020-21  
2019-20  
2018-19  
2017-18  
2016-17  

Research Showcase

10-Nov-21
KR Choksey - Qu..
Download
13-Aug-21
Isec - Quarter ..
Download
12-Nov-20
Isec - Quarter ..
Download
27-Sep-20
Motilal Oswal -..
Download
13-Aug-20
Isec - Quarter ..
Download

Results

31-May-21 Results
11-Feb-21 Results
03-Jun-20 Results
06-Feb-20 Results
13-Nov-19 Results

AGM/EGM/Board Meetings

12-Aug-20 - Quarterly Results & In..
03-Jun-20 - Aurobindo Pharm Ltd
12-Nov-19 - Quarterly Results & In..
07-Aug-19 - Quarterly Results
28-May-19 - Audited Results

Press Release

31-May-21 Press Release
19-Feb-21 Press Release
24-Dec-20 Press Release
09-Dec-20 Press Release
22-Oct-20 Press Release

 

Archived Documents